2017
DOI: 10.1016/j.ajur.2016.11.003
|View full text |Cite
|
Sign up to set email alerts
|

The genetic framework for development of nephrolithiasis

Abstract: Over 1%–15% of the population worldwide is affected by nephrolithiasis, which remains the most common and costly disease that urologists manage today. Identification of at-risk individuals remains a theoretical and technological challenge. The search for monogenic causes of stone disease has been largely unfruitful and a technological challenge; however, several candidate genes have been implicated in the development of nephrolithiasis. In this review, we will review current data on the genetic inheritance of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
18
0
1

Year Published

2017
2017
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(19 citation statements)
references
References 73 publications
0
18
0
1
Order By: Relevance
“…Cystine stones are caused by mutations in the SLC3A1 , SLC7A9 gene or other neighboring genes [64] . In addition, mutation of SLC22A12 and SLC2A9 has also been reported in patients with uric acid calculi [65] . Calcium oxalate stones, the most common type of urinary calculi, are found to be the result of deficiency of enzymes, like alanine glyoxylate aminotransferase (AGT), glyoxylate reductate/hydroxypyruvate reductase (GRHPR) or 4-hydroxy-2-oxoglutarrate aldolase (HOGA1) [65] .…”
Section: Risk Factorsmentioning
confidence: 97%
See 1 more Smart Citation
“…Cystine stones are caused by mutations in the SLC3A1 , SLC7A9 gene or other neighboring genes [64] . In addition, mutation of SLC22A12 and SLC2A9 has also been reported in patients with uric acid calculi [65] . Calcium oxalate stones, the most common type of urinary calculi, are found to be the result of deficiency of enzymes, like alanine glyoxylate aminotransferase (AGT), glyoxylate reductate/hydroxypyruvate reductase (GRHPR) or 4-hydroxy-2-oxoglutarrate aldolase (HOGA1) [65] .…”
Section: Risk Factorsmentioning
confidence: 97%
“…In addition, mutation of SLC22A12 and SLC2A9 has also been reported in patients with uric acid calculi [65] . Calcium oxalate stones, the most common type of urinary calculi, are found to be the result of deficiency of enzymes, like alanine glyoxylate aminotransferase (AGT), glyoxylate reductate/hydroxypyruvate reductase (GRHPR) or 4-hydroxy-2-oxoglutarrate aldolase (HOGA1) [65] . Subsequently, synthesis and excretion of oxalate are increased, resulting in calcium oxalate stone formation.…”
Section: Risk Factorsmentioning
confidence: 97%
“…Nevertheless, we identified PTX3 as a previously unknown endogenous protein inhibitor of intrarenal CaOx crystal growth and adhesion ( 49 ). The field agrees that nephrocalcinosis, kidney stone disease and urolithiasis do not have a monogenic cause ( 54 ). Rather an increasing list of candidate genes is assembled by whole genome genotyping approaches using nephrolithiasis patient cohorts ( 55 , 56 ).…”
Section: Discussionmentioning
confidence: 78%
“…In literature, there is a division into individual and environmental factors [11][12][13][14]. Individual factors include non-modifiable factors such as genetic determinants (mutations in the SLC3A1, SLC7A9, SLC22A12 and SLC2A9 genes or other adjacent ones) [15][16][17], ethnic origin, age, gender and lifestyle factors, i.e., eating habits, body mass index (BMI), dehydration, overweight, obesity, diabetes, hypertension, etc. It should also be noted that the presence of urinary stones may be associated with the occurrence of other diseases [18].…”
Section: Introductionmentioning
confidence: 99%